Benzinga | Jul 2, 2021 04:24PM EDT

Avidity Biosciences Says Entered Into Sales Agreement With Cowen And Company; Says May, From Time To Time, Sell Common Stock Having Offering Price Of Up To $150 Through Cowen

-Reuters